We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANGX
1151
Angel Studios
ANGX
$788M
$124K 0.01%
+26,469
New +$157K
PUBM icon
1152
PubMatic
PUBM
$809M
$122K 0.01%
13,750
-7,518
-35% -$65.5K
ABUS icon
1153
Arbutus Biopharma
ABUS
$907M
$122K 0.01%
25,318
– –
TALO icon
1154
Talos Energy
TALO
$2.6B
$121K 0.01%
10,977
-730
-6% -$7.64K
RAIL icon
1155
FreightCar America
RAIL
$259M
$121K 0.01%
+10,916
New +$100K
PAMT
1156
PAMT Corp
PAMT
$287M
$121K 0.01%
10,000
– –
ADTN icon
1157
Adtran
ADTN
$622M
$119K 0.01%
13,719
-5,681
-29% -$49.3K
FDMT icon
1158
4D Molecular Therapeutics
FDMT
$582M
$118K 0.01%
15,770
-7,230
-31% -$73.3K
UTZ icon
1159
Utz Brands
UTZ
$1.25B
$118K 0.01%
11,385
-5,112
-31% -$55.1K
RBBN icon
1160
Ribbon Communications
RBBN
$367M
$117K 0.01%
40,738
+7,900
+24% +$25.5K
SOHO
1161
DELISTED
Sotherly Hotels
SOHO
$116K 0.01%
+54,052
New +$97K
TEO icon
1162
Telecom Argentina
TEO
$6.16B
$116K 0.01%
+10,000
New +$107K
ACRV icon
1163
Acrivon Therapeutics
ACRV
$74.5M
$116K 0.01%
+48,015
New +$104K
GANX icon
1164
Gain Therapeutics
GANX
$75.5M
$115K 0.01%
35,820
– –
TIC
1165
TIC Solutions Inc
TIC
$2.25B
$115K 0.01%
+11,344
New +$126K
WLACW
1166
DELISTED
Willow Lane Acquisition Corp Warrants
WLACW
$114K 0.01%
+25,500
New +$90.4K
ELPC icon
1167
Copel
ELPC
$8.27B
$114K 0.01%
+12,000
New +$114K
QVCGA
1168
DELISTED
QVC Group Inc Series A
QVCGA
$114K 0.01%
+10,863
New +$118K
ACCO icon
1169
Acco Brands
ACCO
$402M
$113K 0.01%
30,400
– –
BMBL icon
1170
Bumble
BMBL
$360M
$111K 0.01%
31,150
-6,851
-18% -$30.3K
MRLN
1171
Merlin Inc
MRLN
$429M
$109K 0.01%
+10,211
New +$111K
CTOS icon
1172
Custom Truck One Source
CTOS
$2.42B
$109K 0.01%
+18,962
New +$116K
PRCH icon
1173
Porch Group
PRCH
$1.75B
$109K 0.01%
11,911
-9,241
-44% -$111K
UEIC icon
1174
Universal Electronics
UEIC
$71.6M
$108K 0.01%
29,846
+685
+2% +$2.49K
BIVI icon
1175
BioVie
BIVI
$8.3M
$107K 0.01%
92,063
-52,699
-36% -$84.8K
45 46
47
48 49

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.